Nimotuzumab: evidence of clinical benefit without rash

Oncologist. 2005 Oct;10(9):760-1. doi: 10.1634/theoncologist.10-9-760.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / adverse effects*
  • Drug Eruptions / etiology*
  • ErbB Receptors / antagonists & inhibitors*
  • Exanthema / chemically induced*
  • Humans
  • Neoplasms / drug therapy*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • nimotuzumab
  • ErbB Receptors